A patient with relapsed/refractory non-Hodgkin lymphoma received the first dose of a two-step radiotherapy using the ...

Collaborative studies among veterinarians and oncology researchers are yielding new insights into NHL, inspiring innovative ...

The outcome of patients with mantle cell lymphoma (MCL) has largely improved over the past ... Rituximab maintenance was more frequently stopped as a result of causes other than treatment failure ...

In the treatment of non-Hodgkin lymphoma with CD19 chimeric antigen ... patients developed AKI that was determined to have a primary etiology of CD19 CAR T-cell therapy, with no significant ...

Discover the seven primary causes of thyroid disorders affecting women, from autoimmune triggers and hormonal fluctuations to ...

Although cancer incidence rates are rising, overall cancer deaths among young people have not increased. Researchers at the ...

Roughly 200,000 people are diagnosed with a blood cancer on a yearly basis. Blood cancer will claim the lives of 55,000 Americans every year.

A Missouri appellate court has upheld a $611 million verdict awarded to three people who sued Bayer alleging that its Roundup ...

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients with relapsed or refractory mantle cell lymphoma in a phase 1/2 study.In all ...

In a victory for global agrochemical maker Bayer, Georgia has become the second state to shield pesticide manufacturers from some lawsuits claiming that they failed to warn customers of potential ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and ...